Close Menu

NEW YORK (GenomeWeb) – Biocept reported Monday after the close of the market a year-over-year increase in second quarter revenues and commercial testing business volume, but also a higher net loss compared to the previous year.

Separately today, the firm announced a new collaboration with the University of California, Irvine to evaluate its liquid biopsy platform in guiding treatment for metastatic cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.